Home/Filings/4/0001209191-22-048262
4//SEC Filing

Walsh John L 4

Accession 0001209191-22-048262

CIK 0000884614other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:58 PM ET

Size

15.0 KB

Accession

0001209191-22-048262

Insider Transaction Report

Form 4
Period: 2022-08-30
Walsh John L
DirectorPresident & COO
Transactions
  • Exercise/Conversion

    UGI Common Stock

    2022-08-30$27.64/sh+75,000$2,073,000504,734 total
  • Sale

    UGI Common Stock

    2022-08-30$39.51/sh75,000$2,962,950429,734 total
  • Exercise/Conversion

    UGI Common Stock

    2022-09-01$27.64/sh+75,000$2,073,000504,734 total
  • Sale

    UGI Common Stock

    2022-09-01$39.05/sh75,000$2,928,900429,734 total
  • Exercise/Conversion

    Option (Right to Buy)

    2022-08-3075,000225,000 total
    Exercise: $27.64From: 2017-01-01Exp: 2023-12-31UGI Common Stock (75,000 underlying)
  • Exercise/Conversion

    Option (Right to Buy)

    2022-09-0175,000150,000 total
    Exercise: $27.64From: 2017-01-01Exp: 2023-12-31UGI Common Stock (75,000 underlying)
Holdings
  • UGI Common Stock

    (indirect: Benefit Plan)
    2,300
Footnotes (2)
  • [F1]The shares of common stock with respect to this transaction were sold at prices ranging from $39.33 to $39.76. Upon request, UGI Corporation will provide to the Securities and Exchange Commission staff, or a security holder of UGI Corporation, full information regarding the number of shares of common stock sold at each separate price.
  • [F2]The shares of common stock with respect to this transaction were sold at prices ranging from $39.00 to $39.22. Upon request, UGI Corporation will provide to the Securities and Exchange Commission staff, or a security holder of UGI Corporation, full information regarding the number of shares of common stock sold at each separate price.

Issuer

UGI CORP /PA/

CIK 0000884614

Entity typeother

Related Parties

1
  • filerCIK 0001321522

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:58 PM ET
Size
15.0 KB